Protect Yourself.

Protect Your Family

Check for drug interactions

Adverse Drug Reactions are the 4th leading cause of death in the U.S.

GeneMedRx drug interaction software can help reduce the risk.

Click Here
DNA Today
View Current Issue

Sign up to receive the latest updates on advances in DNA testing.


Tamoxifen DNA Test - CYP2D6

tamoxifen

Is your physician thinking of prescribing Tamoxifen?

Are you currently taking Tamoxifen?

Are you concerned about drug effectiveness?

If you answered yes to any of these questions, ask your physician about CYP2D6 testing for tamoxifen.


Genelex will be happy to mail information to you or to your healthcare provider on your behalf, simply complete the request form.


Tamoxifen is a medication for the treatment of breast cancer or for people at a high risk of developing breast cancer.

Recent research has shown that 7-10% of women with breast cancer may not receive the full medical benefit from taking tamoxifen due to their unique genetic make-up. These women have a version of a gene called Cytochrome P450 2D6, which reduces the effectiveness of tamoxifen and increase their chance of breast cancer recurrence. The evidence is so strong that an FDA panel recently recommended that the label of tamoxifen be changed to say that 2D6 poor metabolizers who take tamoxifen have a higher risk for breast cancer recurrence, and that testing is available.( Click here to download tamoxifen 2D6 testing information for your healthcare provider).

DNA Drug Reaction Testing can examine your DNA variations in 2D6 and other important drug processing pathways. Your physician can use this information to adjust dosage and select medications that will be the safest and most effective for you. Since more than 20% of all clinically used medications are metabolized by 2D6, knowing your 2D6 status can help you and your doctor with the future selection of medications.

Genetic testing can tell whether tamoxifen is likely to be an effective treatment for you. This test looks at a specific gene, called 2D6, to determine whether your body can fully metabolize tamoxifen to its active form, endoxifen. If tamoxifen is not an effective treatment, your physician may recommend aromatase inhibitors.

Who Should Be Tested

The CYP2D6 test for tamoxifen is considered appropriate for women who are taking or considering taking tamoxifen to prevent the recurrence of breast cancer. It is especially important if the patient is also taking or considering co-administration with SSRIs.

The Testing Process

The process is simple. You can order testing directly if you have a physician prescription or your healthcare provider can request testing for you. We send a cheek swab collection kit with directions by mail. Use the return mailer to submit samples and receive results in ten days or less. Faster testing is available for an additional charge. Call a DNA testing consultant at (800) 523-3080 for details and to order.

In the News - Mayo study further confirms the importance of CYP2D6 for tamoxifen effectiveness building the case for genotyping and medication management. Click here to read the story.

Note: Testing is currently not available to New York residents and requires a prescription from a physician.

Questions? Call us at 1-800-523-3080
Order your DNA or Paternity Test Today! Request a call Live Chat
Pharmacogenetic testing can help guide clinical medication management
Click Here to Learn More>>
---
Select a Drug or Health Condition

What our clients say...

"I just wanted to call and tell you that my physician switched my medications based on my test results, and I cannot describe how much better I feel. You have made a believer out of me, my family, and my physician. I hope this testing becomes routine before anyone is placed on long term medication."
- PY, Eirie, CO